FTC asks for additional info on Roche's proposed Illumina buy; Covidien reportedly buying Israeli firm for $350M;

@FierceMedDev: Health Care Prosecution Losses Mar U.S. Marketing Probe, via BloombergNews. Story | | Follow @FierceMedDev

> Roche ($RHHBY) has received a request for additional information from the Federal Trade Commission related to its proposed acquisition of Illumina ($ILMN). Roche release

> Covidien ($COV) is reportedly buying Israel's Super-Dimension, which develops devices to diagnose pulmonary diseases, for $350 million. Item

> OptiMedica has nearly tripled its operation size with its new 55,000-square-foot facility in Sunnyvale, CA. It will serve as the base for the company's worldwide commercial launch of the Catalys precision laser system for cataract surgery. OptiMedica release

> Consumer Reports is trying to persuade the American public to question the way devices are approved by the FDA. News

> Doctors are finding that iPads are helping them be more efficient at ordering tests and procedures for their patients. Report

And Finally... A worry in any surgical theater is the air supply not being as sterile as possible. But IMEX's Arc Sterile is helping out by introducing purified, surgical quality air to just about any environment. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.